{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T03:06:55Z","timestamp":1770433615305,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.clineuro.2007.03.008","type":"journal-article","created":{"date-parts":[[2007,5,17]],"date-time":"2007-05-17T13:32:02Z","timestamp":1179408722000},"page":"479-484","source":"Crossref","is-referenced-by-count":58,"title":["Middelheim Fabry Study (MiFaS): A retrospective Belgian study on the prevalence of Fabry disease in young patients with cryptogenic stroke"],"prefix":"10.1016","volume":"109","author":[{"given":"Raf","family":"Brouns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rishi","family":"Sheorajpanday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Braxel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Eyskens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derralynn","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"Timmerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Fran\u00e7oise","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Paul","family":"De Deyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clineuro.2007.03.008_bib1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson\u2013Fabry disease: clinical manifestations and clinical impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"issue":"8","key":"10.1016\/j.clineuro.2007.03.008_bib2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relation between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population","volume":"83","author":"Dobrovolny","year":"2005","journal-title":"J Mol Med"},{"issue":"21","key":"10.1016\/j.clineuro.2007.03.008_bib3","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","article-title":"Clinical features of and recent advances in therapy for Fabry disease","volume":"284","author":"Brady","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clineuro.2007.03.008_bib4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"issue":"2\u20133","key":"10.1016\/j.clineuro.2007.03.008_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0925-4439(00)00024-7","article-title":"Characterization of two alpha-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease","volume":"1501","author":"Kase","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.clineuro.2007.03.008_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1523-1755.2003.00160.x","article-title":"Fabry disease: detection of undiagnosed hemodialysis patients and identification of a \u201crenal variant\u201d phenotype","volume":"64","author":"Nakao","year":"2003","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.clineuro.2007.03.008_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset Fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.clineuro.2007.03.008_bib8","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","article-title":"Prevalence of Anderson\u2013Fabry disease in male patients with late onset hypertrophic cardiomyopathy","volume":"105","author":"Sachdev","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clineuro.2007.03.008_bib9","doi-asserted-by":"crossref","unstructured":"Tsakiris D, Simpson HK, Jones EH, Briggs JD, Elinder CG, Mendel S, et al. Report on management of renal failure in Europe, vol. XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA registry. Nephrol Dial Transplant 1996;11(Suppl. 7):S4\u201320.","DOI":"10.1093\/ndt\/11.supp7.4"},{"issue":"11","key":"10.1016\/j.clineuro.2007.03.008_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of diseases in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.clineuro.2007.03.008_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0303-8467(92)90079-I","article-title":"Fabry's disease presenting with stroke","volume":"94","author":"Grewal","year":"1992","journal-title":"Clin Neurol Neurosurg"},{"issue":"9499","key":"10.1016\/j.clineuro.2007.03.008_bib12","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.clineuro.2007.03.008_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1159\/000071127","article-title":"Registration of stroke through the Belgian sentinel network and factors influencing stroke mortality","volume":"16","author":"Devroey","year":"2003","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.clineuro.2007.03.008_bib14","unstructured":"Van Maldergem L. Oral communication. Brussels; 31 March 2006."},{"issue":"7","key":"10.1016\/j.clineuro.2007.03.008_bib15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.clineuro.2007.03.008_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.clineuro.2007.03.008_bib17","first-page":"61","article-title":"Functional evaluation: the Barthel index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md State Med J"},{"issue":"10","key":"10.1016\/j.clineuro.2007.03.008_bib18","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1136\/jnnp.57.10.1173","article-title":"Validation of a clinical classification for subtypes of acute cerebral infarction","volume":"57","author":"Anderson","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"16","key":"10.1016\/j.clineuro.2007.03.008_bib19","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1093\/nar\/18.16.4957-a","article-title":"Tetranucleotide repeat polymorphism in the vWF gene","volume":"18","author":"Van Amstel","year":"1990","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.clineuro.2007.03.008_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry's disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.clineuro.2007.03.008_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000073054","article-title":"Microembolus detection in four patients with Fabry's disease: further support for a primarily microangiopathic origin of early cerebrovascular symptoms","volume":"50","author":"Ritter","year":"2003","journal-title":"Eur Neurol"},{"issue":"5","key":"10.1016\/j.clineuro.2007.03.008_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.md.0000178976.62537.6b","article-title":"The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease: a cross-sectional study of a large cohort of clinically affected heterozygous women","volume":"84","author":"Gupta","year":"2005","journal-title":"Medicine"},{"issue":"13","key":"10.1016\/j.clineuro.2007.03.008_bib23","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.clineuro.2007.03.008_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"Moore","year":"2002","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.clineuro.2007.03.008_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.2830220110","article-title":"Activation of platelet function in Fabry's disease","volume":"22","author":"Igarashi","year":"1986","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.clineuro.2007.03.008_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/1531-8249(200002)47:2<229::AID-ANA13>3.0.CO;2-T","article-title":"Profile of endothelial and leukocyte activation in Fabry patients","volume":"47","author":"DeGraba","year":"2000","journal-title":"Ann Neurol"},{"issue":"1-2","key":"10.1016\/j.clineuro.2007.03.008_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnosis in dried blood spots on filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin Chim Acta"},{"issue":"1\u20132","key":"10.1016\/j.clineuro.2007.03.008_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.10.019","article-title":"Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers","volume":"353","author":"Linthorst","year":"2005","journal-title":"Clin Chim Acta"},{"issue":"11 Suppl.","key":"10.1016\/j.clineuro.2007.03.008_bib29","first-page":"48","article-title":"Recent advances of Fabry disease screening for at risk population","volume":"21","author":"Caudron","year":"2005","journal-title":"Med Sci"},{"issue":"5","key":"10.1016\/j.clineuro.2007.03.008_bib30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10545-005-0039-4","article-title":"The ratio of alpha-galactosidase to beta-glucuronidase activities in dried blood for the identification of female Fabry disease patients","volume":"28","author":"Lukacs","year":"2005","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.clineuro.2007.03.008_bib31","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/humu.20144","article-title":"Detection of alpha-galactosidase a mutations causing Fabry disase by denaturing high performance liquid chromatography","volume":"25","author":"Shabbeer","year":"2005","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.clineuro.2007.03.008_bib32","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1538-7836.2005.01470.x","article-title":"Homocysteine and tissue factor pathway inhibitor levels in patients with Fabry's disease","volume":"3","author":"Fedi","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.clineuro.2007.03.008_bib33","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00007890-200005270-00022","article-title":"Allograft loss in renal transplant recipients with Fabry's disease and activated protein C resistance","volume":"69","author":"Friedman","year":"2000","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.clineuro.2007.03.008_bib34","first-page":"475","article-title":"Coexistence of Fabry's disease and systemic lupus erythematosus","volume":"16","author":"Rahman","year":"1998","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846707000789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846707000789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T00:26:08Z","timestamp":1556411168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846707000789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0303846707000789"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2007.03.008","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}